Mounjaro weight loss medication: how it works

Wegovy, Ozempic, Saxenda, Rybelsus…in recent years, a wave of new weight loss medications have been approved to treat obesity in the UK. Mounjaro is the most recent of those, having been approved by the MHRA in November 2023.

Mounjaro, Wegovy, and Ozempic: what's the difference?

With the surge of attention around weight loss medications in the media, it's essential to cut through the noise and understand what sets Wegovy, Ozempic, and Mounjaro apart. Let's take a look into the specifics of these treatments.

What are the most common side effects of Mounjaro?

As with any medication, there are a few side effects to be aware of. Let’s run through some of the most common ones, as well as some tips on what to do if you’re experiencing any of them.

How quickly can you expect results with Mounjaro for weight loss?

Recently approved by the MHRA for weight loss, Mounjaro (tirzepatide) represents a significant breakthrough in treatment for those overweight or obese. But a critical question arises: how quickly can you expect results?

Tirzepatide and semaglutide: what’s the difference?

Semaglutide is a tried and tested medication, prescribed for weight loss under the brand name Wegovy. A new treatment, which has also been through rigorous clinical trials, tirzepatide, has demonstrated even greater weight loss effectiveness when combined with a healthy lifestyle.